Eyepoint Pharmaceuticals Inc (EYPT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Eyepoint Pharmaceuticals Inc-Aktie (EYPT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	16.71% 11.68	14.03	15.20	9.105	7.683
Cost Of Revenue	0.759	-	-	-	-
Gross Profit	10.93	-	-	-	-
Operating Expenses	45.63% 44.25	30.38	29.60	31.87	29.24
Interest Income/Expense	-	-	-	0.435	0.812
Benefits Costs and Expenses	46.08% 40.97	28.04	-	-	28.85
Costs And Expenses	60.48% 45.01	28.04	29.60	31.87	28.85
Operating Income/Loss	103.75% -33.32	-16.35	-14.40	-22.76	-21.55
Nonoperating Income/Loss	72.67% 4.037	2.338	1.786	-0.159	0.39
Income/Loss From Continuing Operations Before Tax	108.93% -29.28	-14.02	15.20	9.105	-21.16
Income/Loss From Continuing Operations After Tax	107.70% -29.28	-14.10	-12.61	-22.92	-21.16
Net Income/Loss	107.70% -29.28	-14.10	-12.61	-22.92	-21.16
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	95.19% 0.0529	1.10	38.34	37.58	37.49
Diluted Average Shares	95.19% 0.0529	1.10	38.34	37.58	37.49
Basic Earnings Per Share	71.87% -0.55	-0.32	-0.33	-0.61	-0.56
Diluted Earnings Per Share	71.87% -0.55	-0.32	-0.33	-0.61	-0.56
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$70.39

0.93%

SMMT

$18.42

1.07%

MRNA

$38.25

3.55%

UTHR

$367.36

0.83%

BGNE

$194.56

0.15%

BNTX

$108.23

5.96%